Please provide your email address to receive an email when new articles are posted on . “Although rare, the effect of a painful, spontaneous atypical femur fracture is devastating,” Hanh H. Nguyen, ...

The authors of the study analyzed 166 femur fractures in 119 children with OI Data from a retrospective study of children with osteogenesis imperfecta (OI) suggests that atypical femur fractures are ...

Please provide your email address to receive an email when new articles are posted on . A model factoring in age, femoral neck width and lateral cortical width at lesser trochanter may be able to ...

The relative risk of an atypical femoral fracture with bisphosphonate use related to duration of therapy, with the highest risks being seen after 5 years of exposure, a nationwide study in Denmark ...

Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ibandronate (Boniva) to treat osteoporosis and prevent fragility fractures. Unfortunately, long-term ...

MONTREAL -- Drug holidays among women receiving bisphosphonates markedly reduced the risk of atypical femur fractures, a researcher reported here. "Drug holidays are increasing being used as a method ...

(HealthDay News) — Bisphosphonate use, especially over a long duration, is associated with increased risk of atypical femoral fracture, according to a study published in the September 4 issue of the ...

A recent article examines the relationship between bisphosphonates and atypical fractures of the femur. Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ...

Atypical femoral fractures have been associated with long-term bisphosphonate treatment. 1,2 However, the underlying mechanisms remain obscure. We studied three sisters who had atypical femoral ...

AP X-ray of an 82 year old female with bisphosphonate related atypical transverse stress insufficiency fracture associated with focal lateral cortical thickening of subtrochanteric cortex of proximal ...

Several uncontrolled case series have described atypical subtrochanteric or femoral shaft fractures after long-term bisphosphonate therapy; the presumed mechanism is oversuppression of bone turnover ...

Bisphosphonate use is associated with only a very low risk of atypical fractures to the subtrochanteric or diaphyseal femur, even in women who receive the drugs for up to 10 years, data from an ...